Perioperative antiplatelet in elderly patients aged over 70 years treated with proximal femur fracture: continue or discontinue?
Chul-Young JangDae-Kyung KwakDae-Hwan KimHyung-Min LeeJi-Hyo HwangJe-Hyun YooPublished in: BMC musculoskeletal disorders (2019)
CMN can be performed without delay in elderly patients with proximal femoral fracture receiving antiplatelet therapy prior to admission without discontinuing antiplatelets, and is as safe as in patients who are not on antiplatelet medication. However, more caution is required with respect to transfusions and ICU care after surgery in these patients.
Keyphrases
- antiplatelet therapy
- end stage renal disease
- newly diagnosed
- healthcare
- acute coronary syndrome
- percutaneous coronary intervention
- ejection fraction
- chronic kidney disease
- intensive care unit
- patients undergoing
- cardiac surgery
- middle aged
- quality improvement
- coronary artery disease
- acute kidney injury
- patient reported
- extracorporeal membrane oxygenation
- atrial fibrillation